Señales en vivo de 000627.SZ | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 abr 2024 @ 03:04):

Hubei Biocause Pharmaceutical Co., Ltd. primarily provides life and motor insurance products in China. The company also engages in the pharmaceutical, chemical, and new energy fuel businesses...

Stats
Volumen de hoy	36.81M
Volumen promedio	30.64M
Capitalización de mercado	11.76B
EPS	CNY-0.0515 ( 2023-06-30 )
Próxima fecha de ganancias	( CNY0 ) 2024-05-24
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	-79.33
ATR14	CNY0.0100 (0.42%)

Volumen Correlación

Largo: 0.17 (neutral)

Corto: 0.25 (neutral)

Signal:(55.084) Neutral

Hubei Biocause Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Hubei Biocause Correlación - Moneda/Commodity

0.44
( neutral )

0.36
( neutral )

0.00
( neutral )

0.50
( neutral )

-0.56
( weak negative )

Hubei Biocause Finanzas

Annual	2023
Ingresos:	CNY49.73B
Beneficio Bruto:	CNY49.73B (100.00 %)
EPS:	CNY-0.130

FY	2023
Ingresos:	CNY49.73B
Beneficio Bruto:	CNY49.73B (100.00 %)
EPS:	CNY-0.130

FY	2022
Ingresos:	CNY49.62B
Beneficio Bruto:	CNY41.16B (82.95 %)
EPS:	CNY0.100

FY	2021
Ingresos:	CNY12.20B
Beneficio Bruto:	CNY9.27B (75.97 %)
EPS:	CNY0.100

Financial Reports:

No articles found.

Hubei Biocause

Hubei Biocause Pharmaceutical Co., Ltd. primarily provides life and motor insurance products in China. The company also engages in the pharmaceutical, chemical, and new energy fuel businesses. In addition, it is involved in the contract research and production of APIs, intermediates, and formulations, including tablets, granules, capsules, etc.; and provision of chemicals comprising dimethyl ether gas and a-chloropropionyl chloride. The company exports its products to the United States, the European Union, and internationally. Hubei Biocause Pharmaceutical Co., Ltd. is based in Jingmen, China.